Legal medicine implications in fibrinolytic therapy of acute ischemic stroke
Autor: | Camelia Liana Buhas, Claudia Teodora Judea-Pusta, Monica Sabau, Claudia Jurca, Simona Bungau, Gheorghe Carp, Delia Mirela Tit, Cristian Daina, Bogdan Adrian Buhas, Lucia-Georgeta Daina |
---|---|
Rok vydání: | 2019 |
Předmět: |
Medical negligence
medicine.medical_specialty Time Factors Health (social science) Debate 030204 cardiovascular system & hematology Brain Ischemia 03 medical and health sciences 0302 clinical medicine Stroke thrombolysis Informed consent medicine Humans Thrombolytic Therapy Intensive care medicine Acute ischemic stroke Stroke lcsh:R723-726 Informed Consent Romania business.industry Prevention Health Policy Gold standard Medical jurisprudence medicine.disease humanities Issues ethics and legal aspects Philosophy of medicine Fibrinolytic therapy Medico-legal issues in stroke lcsh:Medical philosophy. Medical ethics business 030217 neurology & neurosurgery |
Zdroj: | BMC Medical Ethics, Vol 20, Iss 1, Pp 1-9 (2019) BMC Medical Ethics |
ISSN: | 1472-6939 |
DOI: | 10.1186/s12910-019-0412-8 |
Popis: | Background Before the advent of fibrinolytic therapy as a gold standard method of care for cases of acute ischemic stroke in Romania, issues regarding legal medicine aspects involved in this area of medical expertise were already presented and, in the majority of cases, the doctors seem to be unprepared for these situations. Main text The present research illustrates some of the cases in which these aspects were involved, that adressed a clinical center having 6 years of professional experience in the application of fibrinolytic treatment for stroke. The following cases report either situations in which the afore mentioned therapy was not rightfully administrated or legal aspects regarding the obtainment of informed consent. Conclusion Obtaining informed consent is a mandatory procedure, which takes time, to the detriment of application of fibrinolytic treatment. |
Databáze: | OpenAIRE |
Externí odkaz: |